Rectal adenocarcinoma metastatic to the tonsil; PET‑CT observations with pathological confirmation: A case report
- Authors:
- Published online on: November 8, 2013 https://doi.org/10.3892/ol.2013.1671
- Pages: 153-155
Abstract
Introduction
Rectal cancer is the common cause of cancer-related mortality in the United States, with ~40,290 new cases in 2012 (1). Rectal tumors spread locally and metastasize to distant sites. The liver is the most common site of metastasis, followed by the regional lymph nodes, lungs and bone (2). The most important prognostic factor in rectal adenocarcinoma is the stage of the tumor, which also indicates the therapeutic strategy. However, accurate detection of rectal carcinoma remains a diagnostic challenge. Although surgery is the most effective primary treatment for rectum carcinoma patients in early stage, it may not be suitable for patients with disseminated metastasis. Therefore, due to incorrect staging, certain patients with disseminated disease may be subjected to unnecessary surgery that may result in considerable morbidity (3). By detecting disease and predicting resectability, positron emission tomography-computed tomography (PET-CT) offers an efficient means to manage such patients. A PET-CT scanner combines PET and CT cameras, and is a new device with significant diagnostic potential. Compared with PET alone, PET-CT shows significant increase in the certainty of lesion localization and characterization of rectal adenocarcinoma (4).
Case report
A 67-year-old male, diagnosed with stage III rectal adenocarcinoma, was admitted to West China Hospital (Chengdu, China) for abdominal rectal resection in May 2010. Postoperative pathological examination indicated mucosal adenocarcinoma, invading the whole intestinal wall and tumor cells were identified in 4/4 mesenteric lymph nodes.
The patient was treated by chemotherapy with oxaliplatin, calcium folinate and fluorouracil every 14 days for seven cycles. In March 2011, PET-CT revealed a left lower lobe nodule with mildly increased glucose metabolism. The largest standardized uptake value (SUV) was 2.38, which exhibited metastatic possibility. The pulmonary nodule was surgically removed and the postoperative pathological diagnosis was a poorly differentiated adenocarcinoma arising from primary rectal adenocarcinoma. The tumor was diagnosed as invading the visceral pleura and immunohistochemical staining showed caudal-type homeobox transcription factor 2 (CDX-2)(+), mucin-1(+), cytokeratin 7 (CK7)(+) and thyroid transcription factor-1 (TTF-1)(−) in the tumor cells (Fig. 1).
Subsequently, the patient was treated by chemotherapy with 50 mg TS-1 twice daily. In November 2011, PET-CT revealed that the tonsil was swollen and the largest SUV was 8.08 (Fig. 2). Pathological examination was performed on the tonsil mass and the results indicated adenocarcinoma. Immunohistochemical staining showed CDX-2(−), CK20(+), CK7(−) and TTF-1(−) in the tumor cells, confirming metastasis from colorectal adenocarcinoma (Fig. 1). The patient was then treated by chemotherapy with irinotecan, calcium folinate and fluorouracil every 14 days for four cycles; however, the patient succumbed to progression of the disease.
Discussion
PET-CT scanning is important in oncology; functional and anatomical images are captured in a single scanning process. The PET-CT approach offers extensive possibilities for improving the diagnosis of primary and metastatic tumors (5). In the present case report, the patient denied any fever, pharyngalgia or night sweats. Thus, PET-CT was considered to be the best tool to identify insidious metastasis, improving radiotherapy planning and monitoring the effects of chemotherapy.
Identification of the primary tumor site is a challenging issue, which has prognostic and therapeutic significance. In the current case report, PET-CT revealed a mass in the left side of the tonsil. To identify the original site of the tumor, immunohistochemistry was performed and the results indicated a CK7(−)/CK20(+) phenotype, which confirmed colorectal carcinoma (6).
Malignant tumors seldom metastasize to the oral cavity. When this occurs, such metastasis is usually from various organs, including the lung, breast and rectum. According to previous studies, a few cases of metastatic localization have been identified from the colon and rectum, including the gingival, alveolar mucosa and tongue (7–9). The current case report presents a case of a 67-year-old male with tonsil metastasis from rectal adenocarcinoma. To the best of our knowledge, this is the first recorded instance of tonsil metastasis from rectal adenocarcinoma.
Since inflammatory and reactive lesions are common in the oral cavity, it is challenging to diagnose the rare case of rectal metastatic tumors in the tonsil. Occasionally, patients with tonsil metastasis clinically mimic patients with the primary tonsil neoplasm or tonsillitis. Therefore, it must be considered in the differential diagnosis of patients with unexplained pharyngalgia and antiadoncus. Careful examination, as well as a multidisciplinary approach, is recommended to validate the clinical suspicion. In conclusion, the current case report presents a unique case of tonsil metastasis from rectal adenocarcinoma and the oncologist must recognize the possibility of tonsil metastasis from malignant disease, such as colorectal cancer.
References
Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar | |
Welch JP and Donaldson GA: The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg. 189:496–502. 1979.PubMed/NCBI | |
Delbeke D, Vitola JV, Sandler MP, Arildsen RC, Powers TA, Wright JK Jr, Chapman WC and Pinson CW: Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med. 38:1196–1201. 1997.PubMed/NCBI | |
Mottaghy FM, Sunderkötter C, Schubert R, et al: Direct comparison of [18F]FDG PET/CT with PET alone and with side-by-side PET and CT in patients with malignant melanoma. Eur J Nucl Med Mol Imaging. 34:1355–1364. 2007. | |
Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R, Jerin J, Young J, Byars L and Nutt R: A combined PET/CT scanner for clinical oncology. J Nucl Med. 41:1369–1379. 2000.PubMed/NCBI | |
Rubin BP, Skarin AT, Pisick E, Rizk M and Salgia R: Use of cytokeratins 7 and 20 in determining the origin of metastatic carcinoma of unknown primary, with special emphasis on lung cancer. Eur J Cancer Prev. 10:77–82. 2001. View Article : Google Scholar | |
Davidson NG and Wilson A: Tongue metastasis from adenocarcinoma of the rectum. J Laryngol Otol. 103:322–323. 1989. View Article : Google Scholar | |
Tomikawa M, Higuchi Y, Saku M, Takeshita M, Yoshida K and Sugimachi K: Carcinoma of the colon metastatic to the lower gingiva. Dig Surg. 18:333–335. 2001. View Article : Google Scholar : PubMed/NCBI | |
Torosian MH, Botet JF and Paglia M: Colon carcinoma metastatic to the thigh - an unusual site of metastasis. Report of a case. Dis Colon Rectum. 30:805–808. 1987. View Article : Google Scholar |